AVAZZIA, INC.

Avazzia, Inc. manufactures prescription-level and over-the-counter microcurrent devices for acute and chronic pain management. The company's proprietary Reaction Technology platform delivers symptomatic relief and pain management lasting up to 24 hours. Avazzia's product portfolio includes the Med-Sport device (over-the-counter for muscle soreness), the BEST-RSI device (prescription-required for acute and chronic pain), and the PRO-SPORT III device with LED display (prescription-required). All devices are FDA-cleared for symptomatic relief and management of chronic, intractable pain, and as adjunctive treatment in post-surgical and post-traumatic pain management. The company maintains a strong commitment to evidence-based clinical research and supports the Paralyzed Veterans Association, with devices available through VA healthcare facilities. Accessories including Y-electrode bundles enable targeted treatment delivery. Founded over two decades ago, Avazzia operates with clinical research support and maintains active engagement with healthcare providers and patient populations seeking non-pharmacological pain relief alternatives.